Literature DB >> 28541136

Metrics Beyond Hemoglobin A1C in Diabetes Management: Time in Range, Hypoglycemia, and Other Parameters.

Lorena Alarcon-Casas Wright1, Irl B Hirsch1.   

Abstract

We review clinical instances in which A1C should not be used and reflect on the use of other glucose metrics that can be used, in substitution of or in combination with A1C and SMBG, to tailor an individualized approach that will result in better outcomes and patient empowerment.

Entities:  

Keywords:  Continuous glucose monitoring; Flash-continuous glucose monitoring; Glucose metrics; Glycemic biomarkers

Mesh：

Substances：

Year:  2017        PMID： 28541136      PMCID： PMC5444503          DOI： 10.1089/dia.2017.0029

Source DB:  PubMed          Journal:  Diabetes Technol Ther        ISSN： 1520-9156            Impact factor:   6.118


  107 in total

1.  Glycated albumin is a better glycemic indicator than glycated hemoglobin values in hemodialysis patients with diabetes: effect of anemia and erythropoietin injection.

Authors:  Masaaki Inaba; Senji Okuno; Yasuro Kumeda; Shinsuke Yamada; Yasuo Imanishi; Tsutomu Tabata; Mikio Okamura; Shigeki Okada; Tomoyuki Yamakawa; Eiji Ishimura; Yoshiki Nishizawa
Journal:  J Am Soc Nephrol       Date:  2007-01-31       Impact factor: 10.121

2.  The loss of postprandial glycemic control precedes stepwise deterioration of fasting with worsening diabetes.

Authors:  Louis Monnier; Claude Colette; Gareth J Dunseath; David R Owens
Journal:  Diabetes Care       Date:  2007-02       Impact factor: 19.112

3.  A newer conversion equation for the correlation between HbA1c and glycated albumin.

Authors:  Kaori Inoue; Tetsuro Tsujimoto; Ritsuko Yamamoto-Honda; Atsushi Goto; Miyako Kishimoto; Hiroshi Noto; Hiroshi Kajio; Seiichi Doi; Sumio Miyazaki; Yasuo Terauchi; Mitsuhiko Noda
Journal:  Endocr J       Date:  2014-03-28       Impact factor: 2.349

4.  Evaluation of a new measure of blood glucose variability in diabetes.

Authors:  Boris P Kovatchev; Erik Otto; Daniel Cox; Linda Gonder-Frederick; William Clarke
Journal:  Diabetes Care       Date:  2006-11       Impact factor: 19.112

Review 5.  Glucose Concentrations of Less Than 3.0 mmol/L (54 mg/dL) Should Be Reported in Clinical Trials: A Joint Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes.

Authors: 
Journal:  Diabetes Care       Date:  2016-11-21       Impact factor: 19.112

6.  Serum levels of 1,5-anhydro-D-glucitol during the normal and diabetic pregnancy and puerperium.

Authors:  M Tetsuo; T Hamada; K Yoshimatsu; J Ishimatsu; T Matsunaga
Journal:  Acta Obstet Gynecol Scand       Date:  1990       Impact factor: 3.636

7.  The relationship of glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the diabetes control and complications trial.

Authors: 
Journal:  Diabetes       Date:  1995-08       Impact factor: 9.461

8.  Relationship of glycated albumin to blood glucose and HbA1c values and to retinopathy, nephropathy, and cardiovascular outcomes in the DCCT/EDIC study.

Authors:  David M Nathan; Paula McGee; Michael W Steffes; John M Lachin
Journal:  Diabetes       Date:  2013-08-29       Impact factor: 9.461

9.  Evaluation of serum 1,5 anhydroglucitol levels as a clinical test to differentiate subtypes of diabetes.

Authors:  Aparna Pal; Andrew J Farmer; Christina Dudley; Mary P Selwood; Beryl A Barrow; Rhiannon Klyne; Jilly P Grew; Mark I McCarthy; Anna L Gloyn; Katharine R Owen
Journal:  Diabetes Care       Date:  2009-11-23       Impact factor: 19.112

10.  Evidence of a strong association between frequency of self-monitoring of blood glucose and hemoglobin A1c levels in T1D exchange clinic registry participants.

Authors:  Kellee M Miller; Roy W Beck; Richard M Bergenstal; Robin S Goland; Michael J Haller; Janet B McGill; Henry Rodriguez; Jill H Simmons; Irl B Hirsch
Journal:  Diabetes Care       Date:  2013-02-01       Impact factor: 19.112
View more
  49 in total

Review 1.  Defining relevant hypoglycemia measures in children and adolescents with type 1 diabetes.

Authors:  T W Jones
Journal:  Pediatr Diabetes       Date:  2017-10-30       Impact factor: 4.866

2.  Clinical Approach to Flash Glucose Monitoring: An Expert Recommendation.

Authors:  Ana Chico; Eva Aguilera; Francisco Javier Ampudia-Blasco; Virgina Bellido; Roque Cardona-Hernández; Francisco Javier Escalada; Diego Fernández; Fernando Gómez-Peralta; Noemí González Pérez de Villar; Juan José Gorgojo; Pedro Mezquita-Raya; Cristóbal Morales; Pedro de Pablos Velasco; Rafael Palomares; Juan Parra; María Teresa Rivero; Cintia González-Blanco
Journal:  J Diabetes Sci Technol       Date:  2019-05-12

3.  Flash Glucose Monitoring: The Future Is Here.

Authors:  Satish K Garg; Halis Kaan Akturk
Journal:  Diabetes Technol Ther       Date:  2017-05       Impact factor: 6.118

Review 4.  Positioning time in range in diabetes management.

Authors:  Andrew Advani
Journal:  Diabetologia       Date:  2019-11-07       Impact factor: 10.122

5.  Identification of clinically relevant dysglycemia phenotypes based on continuous glucose monitoring data from youth with type 1 diabetes and elevated hemoglobin A1c.

Authors:  Anna R Kahkoska; Linda A Adair; Allison E Aiello; Kyle S Burger; John B Buse; Jamie Crandell; David M Maahs; Crystal T Nguyen; Michael R Kosorok; Elizabeth J Mayer-Davis
Journal:  Pediatr Diabetes       Date:  2019-04-29       Impact factor: 4.866

6.  Continuous Glucose Monitoring Associated With Less Diabetes-Specific Emotional Distress and Lower A1c Among Adolescents With Type 1 Diabetes.

Authors:  Anthony T Vesco; Aneta M Jedraszko; Kimberly P Garza; Jill Weissberg-Benchell
Journal:  J Diabetes Sci Technol       Date:  2018-03-29

7.  Estimation of Hemoglobin A1c from Continuous Glucose Monitoring Data in Individuals with Type 1 Diabetes: Is Time In Range All We Need?

Authors:  Chiara Fabris; Lutz Heinemann; Roy Beck; Claudio Cobelli; Boris Kovatchev
Journal:  Diabetes Technol Ther       Date:  2020-07       Impact factor: 6.118

8.  A Review of Continuous Glucose Monitoring-Based Composite Metrics for Glycemic Control.

Authors:  Michelle Nguyen; Julia Han; Elias K Spanakis; Boris P Kovatchev; David C Klonoff
Journal:  Diabetes Technol Ther       Date:  2020-03-04       Impact factor: 6.118

Review 9.  Diabetic Kidney Disease: Is There a Role for Glycemic Variability?

Authors:  Savitha Subramanian; Irl B Hirsch
Journal:  Curr Diab Rep       Date:  2018-02-15       Impact factor: 4.810

10.  Family-Based Interventions Targeting Improvements in Health and Family Outcomes of Children and Adolescents with Type 1 Diabetes: a Systematic Review.

Authors:  Marissa A Feldman; Lindsay M Anderson; Jenna B Shapiro; Aneta M Jedraszko; Meredyth Evans; Lindsey E G Weil; Kimberly P Garza; Jill Weissberg-Benchell
Journal:  Curr Diab Rep       Date:  2018-02-19       Impact factor: 4.810
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.